Global Plasma Fractionation Market Is Expected To Reach $57.34 Billion By 2032

Zion Market Research has published a new report titled “Plasma Fractionation Market by Product (Albumin, Protease Inhibitors, Coagulation Factor Concentrates, Immunoglobulins, and Others), by Application (Immunology, Hematology, Neurology, Rheumatology, Pulmonology, and Others), and by End-User (Hospitals & Clinics, Clinical Research Laboratories, Medical and Academic Institutes, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 – 2032”. According to the report, the global plasma fractionation market was approximately USD 28.21 billion in 2023 and is predicted to grow to around USD 57.34 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.2% between 2024 and 2032.

Plasma processing is a process to obtain pure components that can be further used for injection and transfusion. The Cohn process (also called cold ethanol fractionation) was developed by Edwin J. Cohn during World War II, which was a major breakthrough in the field of blood plasma fractionation. Plasma proteins have biomarkers which help in the detection of rare diseases. This serves many clinical purposes. Plasma contains an innumerable variety of proteins. Around 20 of these proteins serve to produce plasma products, which are used to cure severe plasma conditions.

Browse the full “Plasma Fractionation Market by Product (Albumin, Protease Inhibitors, Coagulation Factor Concentrates, Immunoglobulins, and Others), by Application (Immunology, Hematology, Neurology, Rheumatology, Pulmonology, and Others), and by End-User (Hospitals & Clinics, Clinical Research Laboratories, Medical and Academic Institutes, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 – 2032?” Report at https://www.zionmarketresearch.com/report/plasma-fractionation-market

The increased penetration of the global plasma fractionation market is largely due to the increased use of immunoglobulins and alpha-1-antitrypsin in areas of medicine and the consistent investments in medicine and R&D, which has resulted in cost-effective procedures. The global population has a significant proportion of aged people, who suffer from rare diseases that often require high plasma proteins. There are multiple centers to collect plasma that facilitates smooth treatment and also the subsequent development of the plasma fractionation market globally.

There has been huge governments support for increasing awareness and availability of plasma-derived medicine products for therapeutic usage. Purification methods and chromatographic fractionation have been used for plasma fractionation, which has resulted in the development of plasma products, such as coagulation factors, protease inhibitors, albumin, and immunoglobulin. However, the affordability of plasma products may be a major concern for patients worldwide.

The plasma fractionation market is fragmented on the basis of product, application, and end-user. Based on product, the market is segmented into protease inhibitors, albumin, coagulation factor concentrates (factor IX, prothrombin complex concentrate, factor VIII, Von Willebrand factor, factor XIII, and fibrinogen concentrates), and immunoglobulins (subcutaneous immunoglobulin, intravenous immunoglobulin (IVIG), and other immunoglobulins), and others. The application segment is divided into immunology, hematology, neurology, rheumatology, pulmonology, and others. The end-user segment comprises clinical research laboratories, hospitals and clinics, medical and academic institutes, and others.

North America leads the extraction of plasma proteins and treatment of genetic and blood-related disorders, which makes it the global leader of the plasma fractionation market. The Asia Pacific region exhibits the highest potential to grow notably in the global plasma fractionation market in the years ahead. Increased disposable income, rising lifestyle-related disorders, growing healthcare expenditure, and escalating awareness about health disorders are driving the region’s plasma fractionation market. Additionally, the increasing aging population and cancer prevalence are further driving the plasma fractionation market in the Asia Pacific region.

Plasma Fractionation Market: Competitive players

The key players for plasma fractionation Market are:

• Green Cross
• Biotest
• Octapharma
• LFB
• Japan Blood Products
• China Biologic Products
• CSL
• Shanghai RAAS Blood
• Kedrion
• BPL

This report segments the global plasma fractionation market into:

Plasma Fractionation Market: By Product

• Protease Inhibitors
• Albumin
• Coagulation Factor Concentrates
  • Factor VIII
  • Factor IX
  • Von Willebrand Factor
  • Prothrombin Complex Concentrate
  • Factor XIII
  • Fibrinogen Concentrates
• Immunoglobulins
  • Intravenous Immunoglobulins
  • Subcutaneous Immunoglobulins
  • Other Immunoglobulins
• Others

Plasma Fractionation Market: By Application

• Immunology
• Hematology
• Neurology
• Rheumatology
• Pulmonology
• Others

Plasma Fractionation Market: By End-User

• Hospitals and Clinics
• Clinical Research Laboratories
• Medical and Academic Institutes
• Others

Global Plasma Fractionation Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com